Cardinal Health (NYSE:CAH) is a global healthcare services and products company that provides a broad portfolio of pharmaceuticals, medical products and supply chain technologies. Through its pharmaceutical segment, the company distributes branded and generic drugs, over-the-counter medications and specialty pharmaceuticals to retail pharmacies, hospitals and physician offices. Its medical segment manufactures and distributes medical, surgical and laboratory products, including gloves, fluid management systems, surgical apparel and nuclear medicine products.
In addition to distribution and manufacturing, Cardinal Health offers supply chain consulting, data analytics and business technology solutions designed to optimize inventory management, reduce costs and improve patient care. The company’s technology offerings span pharmacy automation, performance analytics and patient services platforms, supporting health systems, clinics and pharmacies in managing workflows and compliance.
Founded in 1971 and headquartered in Dublin, Ohio, Cardinal Health has grown through strategic acquisitions and organic expansion to serve healthcare providers and manufacturers across North America, with additional operations in Europe and the Asia-Pacific region. Over the decades, the company has expanded its product portfolio and logistics network to help customers navigate complex regulatory environments and evolving industry trends.
Leadership at Cardinal Health is focused on operational excellence, innovation and customer service. Under the direction of Chief Executive Officer Michael Kaufmann, the company is pursuing initiatives in digital transformation, sustainable supply chain practices and enhanced patient outcomes, while maintaining its commitment to quality, safety and financial discipline.
